ULBP/RAET1 Antibodies

Santa Cruz Biotechnology delivers a wide array of ULBP/RAET1 monoclonal antibodies for various research applications. ULBP/RAET1 Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ULBP (UL16 binding protein) and RAET1 (retinoic acid early transcript 1) are essential components in the immune response, interacting with NKG2D receptors on natural killer (NK) cells and T cells to influence cell-mediated cytotoxicity. Expression of ULBP/RAET1 increases during stress or infection, making them key factors in cancer immunology and infectious disease research. Understanding ULBP/RAET1 function reveals important immune evasion mechanisms used by tumors and pathogens. Research in this field continues to uncover new aspects of immune system regulation and potential therapeutic targets. Investigating ULBP/RAET1 expression patterns helps identify novel treatment strategies for various diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system dynamics and developing innovative therapeutic approaches.